Webinar: Covance validate Affimers as critical PK assay reagents


In this free webinar, scientists from leading CRO, Covance, validated the use of Affimer® reagents as critical assay reagents in a regulated pharmacokinetic assay - detecting and quantifying the cancer drug Trastuzumab within standard and disease matrix.

Access the webinar to understand how Affimers offer improved performance within a high-performance assay including:

  • An increased dynamic range compared to current antibody-based methods.
  • Good sensitivity and low matrix effect.
  • No batch-to-batch inconsistencies.

*By registering your email you agree to receive further updates from Avacta Life Sciences about our products and services which are specific to your areas of interest.